Skip to Content

Tobramycin Injection

Last Updated: March 23, 2018
Status: Current

Tobramycin Injection

Products Affected - Description
  • Tobramycin Sulfate solution for injection, Akorn

40 mg/mL, 2 mL vial, 25 count (NDC 17478-0114-02)
40 mg/mL, 30 mL vial, 1 count (NDC 17478-0114-30)
 
Tobramycin Sulfate solution for injection, Mylan Institutional
40 mg/mL, 2 mL vial, 25 count (NDC 67457-0473-22)
 
Tobramycin Sulfate solution for injection, Teva
40 mg/mL, 2 mL vial, 25 count (NDC 00703-9402-04)
 
Tobramycin Sulfate lyophilized powder for solution for injection, X-Gen
1.2 gram, 50 mL preservative-free vial, 6 count (NDC 39822-0412-06)
Reason for the Shortage
    • Akorn has tobramycin injection on shortage due to manufacturing delays.
    • Pfizer did not provide a reason for the shortage.
Available Products
  • Tobramycin Sulfate lyophilized powder for solution for injection, Fresenius Kabi
    1.2 gram, 50 mL preservative-free vial, 6 count (NDC 63323-0303-51)

 
Tobramycin solution for injection, Fresenius Kabi
10 mg/mL, 2 mL vial, 25 count (NDC 63323-0305-02)
40 mg/mL, 2 mL vial, 25 count (NDC 63323-0306-02)
40 mg/mL, 30 mL vial, 10 count (NDC 63323-0306-30)
40 mg/mL, 50 mL vial, 1 count (NDC 63323-0307-51)
 
Tobramycin Sulfate solution for injection, Mylan Institutional
40 mg/mL, 30 mL vial, 10 count (NDC 67457-0428-30)
 
Tobramycin Sulfate solution for injection, Pfizer
40 mg/mL, 2 mL vial, 25 count (NDC 00409-3578-01)
 
Tobramycin Sulfate solution for injection, Teva
40 mg/mL, 30 mL vial, 1 count (NDC 00703-9416-01)
 
Tobramycin Sulfate lyophilized powder for solution for injection, X-Gen
1.2 gram, 50 mL preservative-free vial, 1 count (NDC 39822-0412-01)

Estimated Resupply Dates

    • Akorn has tobramycin 40 mg/mL 2 mL and 30 mL vials available with an expiration date of <11 months.
    • Mylan Institutional has tobramycin 40 mg/mL 2 mL vials on back order and the company estimates a release date of early-May 2018.
    • Teva has temporarily discontinued tobramycin 40 mg/mL 2 mL vials.
    • X-Gen has tobramycin 1.2 gram powder for injection in 6 count on back order and the company estimates a release date of early-April 2018.

Updated

March 23, February 14, January 24, 2018; November 10, October 27, September 6, July 31 and 13, May 3, April 14 and 6, February 27, 2017; December 23, November 21, September 20, August 16, June 28, May 24, April 6, March 21, February 22, January 14, 2016; December 21, November 4, October 28, September 24, August 20, June 15, May 18, April 3, February 27, January 22, 2015; December 12, October 24, September 24, August 28, July 31, June 12, April 11, February 27, January 24, 2014; December 10, November 19, October 24, August 27, July 30, June 19, May 17, January 18, 2012; December 21, November 2, October 29, August 26, July 28, June 24, May 17, April 20, March 10, February 17, 2011; December 21, November 8, September 30, August 18, July 22, June 30, May 28, 2010, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide